Expert insights. Personalized for you.
The Japanese drugmaker has made cell therapy a focus, advancing three experimental cancer treatments into clinical testing with plans for two more MORE
175 
The contract manufacturer aims to capitalize on progress for microbiome-based therapies, a field that's been buoyed by some recent clinical successes MORE
Contract Manufacturing & LogisticsThe company is enhancing its Virginia facility to add an east coast presence for its Analytical Labs division and enhance R&D for pharma ingredients. MORE
Catalent, which is already helping the British pharma make its vaccine, will now add key services from a Maryland gene therapy plant MORE
The global professional services firm has signed on the newest partner in the collaboration, aimed toward promoting innovation in pharma manufacturing. Contract Manufacturing & Logistics MORE
By Dr Ash Ramzan, founder and principal consultant, Woodley BioReg During a pharmaceutical product’s lifetime, it’s widely known and accepted that manufacturing processes will drift within their specified ranges — typically due to equipment wear-and-tear and operator variance. MORE
The rollout of the US COVID-19 vaccination programme slowed up this week because manufacturing delays mean no new doses of the recently approved Johnson & Johnson vaccine are available. The post J&J manufacturing delays hit US vaccine rollout appeared first on. MORE
Integrated CRO/CDMO solutions for accelerated and more efficient early drug development programs MORE
The post COVID-19 Stimulus Legislation Will Cost OTC Manufacturers appeared first on Camargo. Tucked away in the nearly 900 pages of the Coronavirus Aid, Relief, and Economic Security (CARES). MORE
116 Shortages Vaccination and Immunization Coronavirus (2019-nCoV) Factories and Manufacturing Drugs (Pharmaceuticals) Acquired Immune Deficiency SyndromeTwo decades ago, the U.S. launched a program to help supply the world with H.I.V. medication. It should take a similar approach to Covid. MORE
A longer-than-expected timeline for developing a new manufacturing process means a key study for Axovant's top gene therapy likely won't begin until 2022 MORE
A leader from the pharma software solutions provider suggests streamlining communication between shifts can avoid manufacturing snags. Contract Manufacturing & Logistics MORE
ADVANTAGES OF THIRD PARTY MANUFACTURING IN PHARMA INDUSTRY. Amongst various business models used by people in the pharma manufacturing niche, third-party manufacturing is popular. Many people know that the third-party business model gives you a chance to manufacture the products even if you do not have adequate finance. The third-party pharma manufacturing model makes the whole process cost-effective. MORE
The group also discussed Moderna’s COVID-19 vaccine manufacturing partnerships, including its latest deal with South Korea’s Samsung Biologics. Given this, CDMOs like Lonza and Catalent partnered early on with Moderna to manufacture millions of doses of the vaccine. MORE
NuvOx Completes Construction of Expanded Manufacturing Facility. NuvOx Completes Construction of Expanded Manufacturing Facility. TUCSON, Ariz.–(BUSINESS MORE
South African biopharmaceutical company The Biovac Institute will manufacture and distribute Pfizer and BioNTechâs COVID-19 vaccine in Africa, with the three companies signing a letter of intent this week. MORE
Louis van de Wiel, Vice President, Site Head EU Manufacturing, Kite, a Gilead Company, reveals the complexity that sits behind the process of individualised cell therapy – and why team culture makes it work. The post Why cell therapy manufacture is a team sport appeared first on. MORE
BioNTech will acquire Novartisâ GMP certified manufacturing facility in Marburg, Germany: with the site set to become one of the largest mRNA manufacturing plants in Europe. MORE
The two firms are joining forces to help life-sciences customers speed up adoption of continuous manufacturing in pharmaceutical processes. Contract Manufacturing & Logistics MORE
Generate Life Sciences is establishing a GMP facility in La Jolla, California that it says will enable end-to-end manufacturing of newborn stem cell biologics, bolstering supply and safeguarding clinical research. MORE
Collaboration will aim to address challenge of timely and costly AAV-based vector manufacturing MORE
The agency has chosen Continuity Pharma to aid in development and advancement of continuous manufacturing technology, with the help of a $1.5m Contract Manufacturing & Logistics MORE
Solid Dosage Continuous Manufacturing Oral Solid Dosage ShapingTheFuture Syntegon Xelum MORE
A deal to fill vials of Pfizer and BioNTech's vaccine could be the first of several Novartis signs to help others make COVID-19 treatments MORE
The startup manufacturing specialist National Resilience, which raised $800 million when it launched last year, will pay Bluebird $110 million for the North Carolina facility, bringing its North American network up to 10 MORE
226 The agency allows fill-finish activities for Janssenâs COVID-19 vaccine to take place at Catalentâs Italian site. Downstream Processing MORE
Though Alkermes believes it can quickly resolve the issues cited by the agency, the complete response letter nonetheless delays approval of a drug that's critical to the company's hopes of a turnaround MORE
Though it once had a glimmering manufacturing record, Mylan now finds itself in the crosshairs of the FDA. The agency is advising the company to quickly and comprehensively assess its global operations MORE
145 
Taysha Gene Therapies to Host Manufacturing Day Taysha Gene Therapies to Host Manufacturing Day Virtual event on Tuesday, July 27, 2021, at 10:00 a.m. MORE
A leader from the manufacturing technology provider talks about how companies can work to streamline oral solid dose manufacturing to remain competitive. Contract Manufacturing & Logistics MORE
Contract Manufacturing & LogisticsAccording to a leader from industrial AI specialist AspenTech, AI can help avoid costly maintenance interruptions by predicting when upkeep is needed. MORE
Thermo Fisher Scientific continues to open new facilities that enable it to meet increasing manufacturing demands MORE
The New Jersey facility that ran afoul of FDA manufacturing standards is one of several Lilly is using to produce coronavirus antibody drugs MORE
The French pharma has agreed to "fill and finish" up to 200 million vials of Moderna's shot at its New Jersey plant, the third such manufacturing deal it struck with other vaccine developers MORE
For the past year, life science companies around the world worked at breakneck speed to develop and manufacture safe and effective treatments to respond to the COVID-19 pandemic. His experience spans sales & marketing, business development, R&D, manufacturing and operations. MORE
Now, researchers at Stanford University have invented a manufacturing technique that yields flexible, atomically thin transistors less than 100 nanometers in length – several times […]. MORE
One vaccine batch being manufactured for J&J by Emergent Biosolutions failed quality checks, reportedly ruining material sufficient for up to 15 million doses MORE
The Novartis plant will help BioNTech and partner Pfizer make 750 million doses of their shot per year, and become one of the largest messenger RNA manufacturing sites in Europe MORE
The small-molecule pharmaceuticals manufacturer secured a DoD/HHS government contract to manufacture critical medicines, including a COVID-19 treatment. Contract Manufacturing & Logistics MORE
The Serum Institute of India, a go-to partner for coronavirus vaccine makers, will help Novavax boost capacity to levels matching its larger rivals MORE
Catamaran Bio Announces Appointment of Joseph Gold, PhD, as Vice President, Technical Operations and Manufacturing Catamaran Bio Announces Appointment of Joseph Gold, PhD, as Vice President, Technical Operations and Manufacturing CAMBRIDGE, Mass.–(BUSINESS MORE
52 
Swiss CDMO Lonza Group has announced plans to expand manufacturing at its sites in Visp, Switzerland and Portsmouth, New Hampshire in the US, committing $950 million to the projects. MORE
Manufacturing Related Topics Bio Pharma Dive
JULY 29, 2021
The startup manufacturing specialist National Resilience, which raised $800 million when it launched last year, will pay Bluebird $110 million for the North Carolina facility, bringing its North American network up to 10
Outsourcing Pharma
MAY 17, 2021
Contract Manufacturing & LogisticsAccording to a leader from industrial AI specialist AspenTech, AI can help avoid costly maintenance interruptions by predicting when upkeep is needed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
APRIL 1, 2021
One vaccine batch being manufactured for J&J by Emergent Biosolutions failed quality checks, reportedly ruining material sufficient for up to 15 million doses
Syntegon Technology Pharma Blog
OCTOBER 28, 2020
Solid Dosage Continuous Manufacturing Oral Solid Dosage ShapingTheFuture Syntegon Xelum
Bio Pharma Dive
SEPTEMBER 3, 2020
Though it once had a glimmering manufacturing record, Mylan now finds itself in the crosshairs of the FDA. The agency is advising the company to quickly and comprehensively assess its global operations
Bio Pharma Dive
OCTOBER 30, 2020
A longer-than-expected timeline for developing a new manufacturing process means a key study for Axovant's top gene therapy likely won't begin until 2022
Outsourcing Pharma
SEPTEMBER 21, 2020
A leader from the pharma software solutions provider suggests streamlining communication between shifts can avoid manufacturing snags. Contract Manufacturing & Logistics
Outsourcing Pharma
NOVEMBER 4, 2020
The agency has chosen Continuity Pharma to aid in development and advancement of continuous manufacturing technology, with the help of a $1.5m Contract Manufacturing & Logistics
Camargo
APRIL 2, 2020
The post COVID-19 Stimulus Legislation Will Cost OTC Manufacturers appeared first on Camargo. Tucked away in the nearly 900 pages of the Coronavirus Aid, Relief, and Economic Security (CARES).
Outsourcing Pharma
JUNE 8, 2021
A leader from the manufacturing technology provider talks about how companies can work to streamline oral solid dose manufacturing to remain competitive. Contract Manufacturing & Logistics
Outsourcing Pharma
FEBRUARY 11, 2021
The global professional services firm has signed on the newest partner in the collaboration, aimed toward promoting innovation in pharma manufacturing. Contract Manufacturing & Logistics
Bio Pharma Dive
APRIL 26, 2021
The French pharma has agreed to "fill and finish" up to 200 million vials of Moderna's shot at its New Jersey plant, the third such manufacturing deal it struck with other vaccine developers
Bio Pharma Dive
JANUARY 29, 2021
A deal to fill vials of Pfizer and BioNTech's vaccine could be the first of several Novartis signs to help others make COVID-19 treatments
Bio Pharma Dive
OCTOBER 22, 2020
The New Jersey facility that ran afoul of FDA manufacturing standards is one of several Lilly is using to produce coronavirus antibody drugs
Pharma Mirror
JUNE 24, 2021
By Dr Ash Ramzan, founder and principal consultant, Woodley BioReg During a pharmaceutical product’s lifetime, it’s widely known and accepted that manufacturing processes will drift within their specified ranges — typically due to equipment wear-and-tear and operator variance.
Outsourcing Pharma
JANUARY 21, 2021
The small-molecule pharmaceuticals manufacturer secured a DoD/HHS government contract to manufacture critical medicines, including a COVID-19 treatment. Contract Manufacturing & Logistics
Pharma Phorum
MARCH 22, 2021
For the past year, life science companies around the world worked at breakneck speed to develop and manufacture safe and effective treatments to respond to the COVID-19 pandemic. His experience spans sales & marketing, business development, R&D, manufacturing and operations.
BioPharma Reporter
JULY 22, 2021
Generate Life Sciences is establishing a GMP facility in La Jolla, California that it says will enable end-to-end manufacturing of newborn stem cell biologics, bolstering supply and safeguarding clinical research.
Pharma Phorum
JANUARY 6, 2021
Louis van de Wiel, Vice President, Site Head EU Manufacturing, Kite, a Gilead Company, reveals the complexity that sits behind the process of individualised cell therapy – and why team culture makes it work. The post Why cell therapy manufacture is a team sport appeared first on.
BioPharma Reporter
JULY 21, 2021
South African biopharmaceutical company The Biovac Institute will manufacture and distribute Pfizer and BioNTechâs COVID-19 vaccine in Africa, with the three companies signing a letter of intent this week.
Bio Pharma Dive
SEPTEMBER 15, 2020
The Japanese drugmaker has made cell therapy a focus, advancing three experimental cancer treatments into clinical testing with plans for two more
Syntegon Technology Pharma Blog
DECEMBER 1, 2020
Pharma Services Qualification/Validation
BioSpace
JULY 14, 2021
Thermo Fisher Scientific continues to open new facilities that enable it to meet increasing manufacturing demands
Bio Pharma Dive
SEPTEMBER 30, 2020
The contract manufacturer aims to capitalize on progress for microbiome-based therapies, a field that's been buoyed by some recent clinical successes
Fossil Remedies
JULY 18, 2019
ADVANTAGES OF THIRD PARTY MANUFACTURING IN PHARMA INDUSTRY. Amongst various business models used by people in the pharma manufacturing niche, third-party manufacturing is popular. Many people know that the third-party business model gives you a chance to manufacture the products even if you do not have adequate finance. The third-party pharma manufacturing model makes the whole process cost-effective.
BioTech 365
APRIL 30, 2021
NuvOx Completes Construction of Expanded Manufacturing Facility. NuvOx Completes Construction of Expanded Manufacturing Facility. TUCSON, Ariz.–(BUSINESS
BioTech 365
AUGUST 2, 2021
Catamaran Bio Announces Appointment of Joseph Gold, PhD, as Vice President, Technical Operations and Manufacturing Catamaran Bio Announces Appointment of Joseph Gold, PhD, as Vice President, Technical Operations and Manufacturing CAMBRIDGE, Mass.–(BUSINESS
Outsourcing Pharma
MAY 19, 2021
Contract Manufacturing & LogisticsThe company is enhancing its Virginia facility to add an east coast presence for its Analytical Labs division and enhance R&D for pharma ingredients.
XTalks
JUNE 9, 2021
The group also discussed Moderna’s COVID-19 vaccine manufacturing partnerships, including its latest deal with South Korea’s Samsung Biologics. Given this, CDMOs like Lonza and Catalent partnered early on with Moderna to manufacture millions of doses of the vaccine.
Bio Pharma Dive
NOVEMBER 17, 2020
Though Alkermes believes it can quickly resolve the issues cited by the agency, the complete response letter nonetheless delays approval of a drug that's critical to the company's hopes of a turnaround
Bio Pharma Dive
SEPTEMBER 15, 2020
The Serum Institute of India, a go-to partner for coronavirus vaccine makers, will help Novavax boost capacity to levels matching its larger rivals
NY Times
JANUARY 12, 2021
Shortages Vaccination and Immunization Coronavirus (2019-nCoV) Factories and Manufacturing Drugs (Pharmaceuticals) Acquired Immune Deficiency SyndromeTwo decades ago, the U.S. launched a program to help supply the world with H.I.V. medication. It should take a similar approach to Covid.
Scienmag
JUNE 17, 2021
Now, researchers at Stanford University have invented a manufacturing technique that yields flexible, atomically thin transistors less than 100 nanometers in length – several times […].
Pharma Times
MAY 24, 2021
Collaboration will aim to address challenge of timely and costly AAV-based vector manufacturing
Bio Pharma Dive
SEPTEMBER 17, 2020
The Novartis plant will help BioNTech and partner Pfizer make 750 million doses of their shot per year, and become one of the largest messenger RNA manufacturing sites in Europe
Bio Pharma Dive
AUGUST 26, 2020
Catalent, which is already helping the British pharma make its vaccine, will now add key services from a Maryland gene therapy plant
Bio Pharma Dive
DECEMBER 7, 2020
Integrated CRO/CDMO solutions for accelerated and more efficient early drug development programs
BioPharma Reporter
SEPTEMBER 17, 2020
BioNTech will acquire Novartisâ GMP certified manufacturing facility in Marburg, Germany: with the site set to become one of the largest mRNA manufacturing plants in Europe.
BioPharma Reporter
JUNE 29, 2021
The agency allows fill-finish activities for Janssenâs COVID-19 vaccine to take place at Catalentâs Italian site. Downstream Processing
XTalks
MAY 11, 2021
Swiss CDMO Lonza Group has announced plans to expand manufacturing at its sites in Visp, Switzerland and Portsmouth, New Hampshire in the US, committing $950 million to the projects.
Pharma Phorum
MARCH 10, 2021
The rollout of the US COVID-19 vaccination programme slowed up this week because manufacturing delays mean no new doses of the recently approved Johnson & Johnson vaccine are available. The post J&J manufacturing delays hit US vaccine rollout appeared first on.
Outsourcing Pharma
NOVEMBER 4, 2020
The two firms are joining forces to help life-sciences customers speed up adoption of continuous manufacturing in pharmaceutical processes. Contract Manufacturing & Logistics
Let's personalize your content